Twice‐daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice‐daily omeprazole, rabeprazole or lansoprazole

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 9, 2013-11 ,pp. : 1129-1137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma

By Knox A   Langan J   Martinot J-B   Gruss C   Häfner D  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2387-2394

Informa Healthcare

Access to resources Recommend Favorite

Conversion from twice‐daily to once‐daily tacrolimus formulation in pediatric liver transplant recipients – a long‐term prospective study

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 31, Iss. 1, 2018-01 ,pp. : 38-44

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

By van Seventer Robert   Feister Hilary A.   Young James P.   Stoker Malcolm   Versavel Mark   Rigaudy Laurence  

Current Medical Research and Opinion, Vol. 22, Iss. 2, 2006-02 ,pp. : 375-384

Informa Healthcare

Access to resources Recommend Favorite

Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study

By Riffer Ernie   Spiller Joy   Palmer Robert   Shortridge Virginia   Busman Todd A.   Valdes Joaquin  

Current Medical Research and Opinion, Vol. 21, Iss. 1, 2005-01 ,pp. : 61-70

Informa Healthcare

Access to resources Recommend Favorite